European Medical Solutions (LTS:0RGO) Short Interest


LTS:0RGO European Medical Solutions LTS:0RGO
43 GF Score
Price €4.70
GF Value €9.64
! 2 Warning Signs
View Full Analysis

What is European Medical Solutions Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

LTS:0RGO vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, European Medical Solutions's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

European Medical Solutions Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, European Medical Solutions's Short Interest distribution charts can be found below:

* The bar in red indicates where European Medical Solutions's Short Interest falls into.


LTS:0RGO
43GF Score
European Medical Solutions LTS:0RGO
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is European Medical Solutions (LTS:0RGO) Overvalued in 2026?

Based on GuruFocus' analysis, European Medical Solutions stock appears to be undervalued. The current stock price of €4.70 is trading 51.2% below its estimated GF Value™ of €9.64.

Key valuation signals for LTS:0RGO:

  • Short Interest:
  • GF Value™: €9.64 vs. price of €4.70 (51.2% below fair value)
  • GF Score™: 43/100 with 2 warning signs

No single metric tells the full story. See the LTS:0RGO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

European Medical Solutions Business Description

Other Exchanges ALEMS:Belgium
Address 7 Rue des Chasseurs Ardennais, Liege, BEL, 4031
European Medical Solutions Formerly DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.
43GF Score

Get the complete analysis for LTS:0RGO

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.70
Price
€9.64
GF Value